ENTRY       D04554                      Drug
NAME        Interferon beta-1a (USAN);
            Interferon beta-1a (genetical recombination) (JAN);
            Avonex (TN);
            Rebif (TN)
PRODUCT     INTERFERON BETA-1A (Biogen)
            INTERFERON BETA-1A (EMD Serono)
FORMULA     C908H1406N246O252S7
EXACT_MASS  20012.2812
MOL_WEIGHT  20024.8312
SEQUENCE    MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLQQF QKEDAALTIY
            EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL
            HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN
            (Disulfide bridge: 31-141)
  TYPE      Peptide
CLASS       Immunological agent
             DG01752  Interferone
REMARK      Therapeutic category: 6399
            ATC code: L03AB07
            Chemical structure group: DG01751
            Product (DG01751): D00746<JP/US> D03304<JP> D04554<JP/US>
EFFICACY    Antineoplastic, Biological response modifier
  DISEASE   Multiple sclerosis [DS:H01490]
TARGET      IFNAR1 [HSA:3454] [KO:K05130]
            IFNAR2 [HSA:3455] [KO:K05131]
  PATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction
            hsa04620(3454+3455)  Toll-like receptor signaling pathway
            hsa04630(3454+3455)  JAK-STAT signaling pathway
            hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AB Interferons
                 L03AB07 Interferon beta-1a
                  D04554  Interferon beta-1a (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Multiple Sclerosis Agents
               Interferon Beta-1a
                D04554  Interferon beta-1a (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D04554  Interferon beta-1a (USAN); Interferon beta-1a (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01751  Interferon beta
                D04554  Interferon beta-1a
            Drug classes [BR:br08332]
             Immunological agent
              DG01752  Interferone
               D04554  Interferon beta-1a
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interferon receptors
                IFNAR1
                 D04554  Interferon beta-1a (USAN) &lt;JP/US&gt;
                IFNAR2
                 D04554  Interferon beta-1a (USAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04554
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04554
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01751  Interferon beta
DBLINKS     CAS: 145258-61-3
            PubChem: 47206399
///
